Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.
about
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanismStructural basis of transfer between lipoproteins by cholesteryl ester transfer protein.Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles.The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteinsStreptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterolSerum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.Structural stability and functional remodeling of high-density lipoproteins.Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).New molecular insights into CETP structure and function: a review.Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.Cryo-electron microscopy of extracellular vesicles in fresh plasma.Structural Stability of Streptococcal Serum Opacity Factor.Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1.Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
P2860
Q28829054-93787C13-E358-4C7E-B653-17A6FDE3CA1FQ30155371-49539887-912C-4C26-A671-AB3D9200CB9DQ33634176-F6E4E936-7AD0-4502-B734-A1A1A011DA43Q34022219-BD60291B-4540-4944-9C1F-47BB388BCA8FQ34315738-F9285C66-2FAA-497D-9107-7F9A983FBDE2Q34562290-494572A7-1897-4710-B07D-E6415B437E42Q35609905-D5139C42-FBC3-48E5-9DDF-37EE896212E2Q35886290-9A4C835B-DEDF-46BC-9770-BC4ADE7DE529Q36031087-EE7EC88A-EE19-4DC0-830F-9DB3C4F36CBFQ36106782-0408052E-8C1A-40AB-B00C-F88C6277EE01Q36520363-28FB8ABA-990F-4A52-AB2C-CFFC7A56DAA1Q37252779-B316C64B-6227-4DEF-A8CE-028265695D1DQ37491689-09581B07-B568-41F5-8C77-FA2EE4E88179Q38857079-C2BB5DDC-36FB-497C-B7E2-7F19B1CBA9CAQ38857612-BD74AFB0-8DDA-4096-BCB8-1F05CD7FF25FQ43136808-CB3048C7-AF84-4295-A0A5-0BF905E43C18Q55417373-06BFF900-1FA5-4B4E-A492-B404A884008C
P2860
Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Disruption of human plasma hig ...... res labile apolipoprotein A-I.
@en
type
label
Disruption of human plasma hig ...... res labile apolipoprotein A-I.
@en
prefLabel
Disruption of human plasma hig ...... res labile apolipoprotein A-I.
@en
P2093
P2860
P356
P1433
P1476
Disruption of human plasma hig ...... res labile apolipoprotein A-I.
@en
P2093
Baiba K Gillard
Corina Rosales
Harry S Courtney
Henry J Pownall
Htet Khant
Kathryn Ward
Mikyung Han
Steven J Ludtke
P2860
P304
P356
10.1021/BI802287Q
P407
P577
2009-02-01T00:00:00Z